Topic starter
24/06/2026 6:57 pm
TL;DR: ALCOA remains the core data integrity model for life sciences because compliance failures usually begin with weak process discipline, not bad intent, according to Collibra. The governance lesson is that traceability, auditability, and contemporaneous control matter as much as the system storing the record.
Editorial analysis by NHI Mgmt Group, based on content published by Collibra: “Clinical and operational data is as trustworthy as the processes behind it”.
Key questions
Q: What breaks when clinical records are updated outside controlled governance?
A: The record stops being attributable and contemporaneous, which means reviewers cannot reliably prove who changed it, when it changed, or whether the original value survived.
Q: Why do ALCOA failures create regulatory risk even without malicious intent?
A: Because regulators assess whether the process can defend the record, not whether the person intended harm.
Q: How can teams tell whether their audit trails are actually working?
A: Look for whether every material change is traceable to a person, time, and reason, and whether the review process is routine rather than occasional.
Practitioner guidance
- Tighten record-correction workflows Require timestamped corrections, preserved originals, and documented rationale for every material change to regulated records.
- Validate audit trail review Confirm that audit trails are not only generated but routinely reviewed, protected, and tested for completeness across systems.
- Define data ownership in practice Assign accountable owners for clinical and laboratory records so provenance, correction approval, and review obligations are explicit.
Bottom line: ALCOA failures usually begin with ordinary process shortcuts, which is why governance discipline matters more than the storage platform itself.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
25/06/2026 3:59 am
ALCOA is fundamentally a governance model, not a records format. The article correctly shows that life sciences failures often begin with process shortcuts rather than malicious intent. That means the real control question is whether the organisation can prove who changed what, when, and why. For practitioners, the lesson is that data integrity lives or dies in the operating model, not in the database.
A question worth separating out:
Q: What is the difference between data integrity controls and data storage controls?
A: Storage controls keep the data available, but integrity controls prove the data is trustworthy over time. ALCOA depends on provenance, timing, and accountable correction, so a secure repository alone does not satisfy the governance requirement if the record can be altered without clear evidence.
👉 Read our full editorial: ALCOA data integrity exposes the governance gap in clinical records